Browsing by Author "Falcón, Carlos"

Now showing items 1-4 of 4

    • Characteristic brain volumetric changes in the AD preclinical signature 

      Petrone, Paula; Casamitjana Díaz, Adrià; Falcón, Carlos; Artigues, Miquel; Operto, Grégory; Skouras, Stavros; Cacciaglia, Raffaele; Molinuevo, Jose Luis; Vilaplana Besler, Verónica; Gispert, Juan Domingo; Salvado, Gemma (Elsevier, 2018)
      Article
      Open Access

    • MRI-based screening of preclinical Alzheimer's disease for prevention clinical trials 

      Casamitjana Díaz, Adrià; Petrone, Paula; Tucholka, Alan; Falcón, Carlos; Skouras, Stavros; Molinuevo, José Luis; Vilaplana Besler, Verónica; Gispert, Juan Domingo (IOS Press, 2018)
      Article
      Open Access
      The identification of healthy individuals harboring amyloid pathology represents one important challenge for secondary prevention clinical trials in Alzheimer’s disease (AD). Consequently, noninvasive and cost-efficient ...

    • NeAT: a nonlinear analysis toolbox for neuroimaging 

      Casamitjana Díaz, Adrià; Vilaplana Besler, Verónica; Puch Giner, Santi; Aduriz Saiz, Asier; Operto, Grégory; Cacciaglia, Raffaele; Falcón, Carlos; Molinuevo, José Luis; Gispert, Juan Domingo; López Molina, Carlos Alejandro (2020-03-25)
      Article
      Open Access
      NeAT is a modular, flexible and user-friendly neuroimaging analysis toolbox for modeling linear and nonlinear effects overcoming the limitations of the standard neuroimaging methods which are solely based on linear models. ...

    • Prediction of amyloid pathology in cognitively unimpaired individuals using voxel-wise analysis of longitudinal structural brain MRI 

      Petrone, Paula; Casamitjana Díaz, Adrià; Falcón, Carlos; Artigues, Miquel; Operto, Grégory; Cacciaglia, Raffaele; Molinuevo, José Luis; Vilaplana Besler, Verónica; Gispert, Juan Domingo (2019-08-17)
      Article
      Open Access
      Background Magnetic resonance imaging (MRI) has unveiled specific alterations at different stages of Alzheimer’s disease (AD) pathophysiologic continuum constituting what has been established as “AD signature”. To what ...